What is the price of osimertinib after medical insurance reimbursement? What is the specific reimbursement process?

Osimertinib, as an important drug for the treatment of adult patients with metastaticEGFR T790M mutation-positive non-small cell lung cancer, has a significant therapeutic effect, especially for those patients whose disease has progressed during or after EGFR TKI treatment. However, the high cost of treatment has always been a major burden for patients and their families. Fortunately, osimertinib has been included in the reimbursement scope of my country's medical insurance, providing financial support to patients.

After reimbursement by medical insurance, the price of osimertinib will be significantly reduced compared to the original price. The specific price after reimbursement varies according to different regions and medical insurance policies. Patients can enjoy more affordable treatment costs through medical insurance reimbursement policies, thereby alleviating financial pressure.

In terms of the reimbursement process, patients need to first go to a designated medical institution and a professional doctor will issue a prescription for osimertinib. Subsequently, the patient needs to bring the prescription and medical insurance card to a medical insurance designated pharmacy to purchase drugs. The pharmacy will reimburse part of the cost according to local medical insurance policies, and the patient only needs to pay the remaining out-of-pocket portion. This process ensures the smooth acquisition and reimbursement of drugs, providing great convenience to patients.

For patients with greater financial pressure, in addition to medical insurance reimbursement policies, generic drugs can also be considered. The price of generic osimertinib drugs produced by Lao Lucius Pharmaceuticals, Lao United Pharmaceuticals, Lao Second Pharmaceutical Factory and Lao ASEAN Pharmaceuticals is more affordable than the original drug. A box of 80mg*30 tablets is priced between 500 to 600 yuan. However, when choosing generic drugs, patients should ensure that they come from reliable sources and use them under the guidance of a doctor.

In short, medical insurance reimbursement policies and the emergence of generic drugs have provided patients with more treatment options and financial support. When choosing a treatment plan, patients should comprehensively consider their own financial situation, treatment effects, and doctor's recommendations to develop a treatment plan that best suits them.